Unit
Division of Infectious Diseases, Infection Prevention and Travel Medicine
INFEKT · Dept. I
Prevalence of adverse events associated with potent antiretroviral treatment: Swiss HIV Cohort Study
Fellay J, Telenti A, Flepp M, Greub G, Francioli P, Vernazza P, Hirschel B, Battegay M, Furrer H, Bernasconi E, Ledergerber B, Boubaker K, Swiss HIV Cohort Study. Prevalence of adverse events associated with potent antiretroviral treatment: Swiss HIV Cohort Study. Lancet 2001; 358:1322-7.
Oct 20, 2001Prevalence of adverse events associated with potent antiretroviral treatment: Swiss HIV Cohort Study
Oct 20, 2001Lancet 2001; 358:1322-7
Fellay J, Telenti A, Flepp M, Greub G, Francioli P, Vernazza Pietro, Hirschel B, Battegay M, Furrer H, Bernasconi E, Ledergerber B, Boubaker K, Swiss HIV Cohort Study
A single-nucleotide polymorphism in the sterol-regulatory element-binding protein 1c gene is predictive of HIV-related hyperlipoproteinaemia
Miserez A, Muller P, Barella L, Schwietert M, Erb P, Vernazza P, Battegay M, Swiss HIV Cohort Study. A single-nucleotide polymorphism in the sterol-regulatory element-binding protein 1c gene is predictive of HIV-related hyperlipoproteinaemia. AIDS (London, England) 2001; 15:2045-9.
Oct 19, 2001A single-nucleotide polymorphism in the sterol-regulatory element-binding protein 1c gene is predictive of HIV-related hyperlipoproteinaemia
Oct 19, 2001AIDS (London, England) 2001; 15:2045-9
Miserez A R, Muller P Y, Barella L, Schwietert M, Erb P, Vernazza Pietro, Battegay M, Swiss HIV Cohort Study
Disseminated M. avium complex infection in the Swiss HIV Cohort Study: declining incidence, improved prognosis and discontinuation of maintenance therapy
Rossi M, Furrer H, Rickenbach M, Weber R, Bernasconi E, Vernazza P, Bucher H, Egloff N, Schiffer V, Telenti A, Flepp M, Swiss HIV Cohort Study. Disseminated M. avium complex infection in the Swiss HIV Cohort Study: declining incidence, improved prognosis and discontinuation of maintenance therapy. Swiss medical weekly : official journal of the Swiss Society of Infectious Diseases, the Swiss Society of Internal Medicine, the Swiss Society of Pneumology 2001; 131:471-7.
Aug 11, 2001Disseminated M. avium complex infection in the Swiss HIV Cohort Study: declining incidence, improved prognosis and discontinuation of maintenance therapy
Aug 11, 2001Swiss medical weekly : official journal of the Swiss Society of Infectious Diseases, the Swiss Society of Internal Medicine, the Swiss Society of Pneumology 2001; 131:471-7
Rossi M, Furrer H, Rickenbach M, Weber R, Bernasconi E, Vernazza Pietro, Bucher H, Egloff N, Schiffer V, Telenti A, Flepp M, Swiss HIV Cohort Study
Long-term evaluation of T-cell subset changes after effective combination antiretroviral therapy during asymptomatic HIV-infection
Bisset L, Opravil M, Grob P, Weber R, Dubs R, Vernazza P, Battegay M, Fischer M, Cone R, Swiss HIV Cohort Study. Long-term evaluation of T-cell subset changes after effective combination antiretroviral therapy during asymptomatic HIV-infection. Journal of acquired immune deficiency syndromes (1999) 2001; 27:266-71.
Jul 1, 2001Long-term evaluation of T-cell subset changes after effective combination antiretroviral therapy during asymptomatic HIV-infection
Jul 1, 2001Journal of acquired immune deficiency syndromes (1999) 2001; 27:266-71
Bisset L R, Opravil M, Grob P J, Weber R, Dubs R W, Vernazza Pietro, Battegay M, Fischer M, Cone R W, Swiss HIV Cohort Study
HIV transmission after suspension of highly active antiretroviral therapy
Bernasconi E, Vernazza P, Bernasconi A, Hirschel B, Swiss HIV Cohort Study. HIV transmission after suspension of highly active antiretroviral therapy. Journal of acquired immune deficiency syndromes (1999) 2001; 27:209.
Jun 1, 2001HIV transmission after suspension of highly active antiretroviral therapy
Jun 1, 2001Journal of acquired immune deficiency syndromes (1999) 2001; 27:209
Bernasconi E, Vernazza Pietro, Bernasconi A, Hirschel B, Swiss HIV Cohort Study
Longitudinal sero-reactivity to human herpesvirus 8 (KSHV) in the Swiss HIV Cohort 4.7 years before KS
Quinlivan E, Wang R, Stewart P, Kolmoltri C, Regamey N, Erb P, Vernazza P, Swiss HIV Cohort Study. Longitudinal sero-reactivity to human herpesvirus 8 (KSHV) in the Swiss HIV Cohort 4.7 years before KS. Journal of medical virology 2001; 64:157-66.
Jun 1, 2001Longitudinal sero-reactivity to human herpesvirus 8 (KSHV) in the Swiss HIV Cohort 4.7 years before KS
Jun 1, 2001Journal of medical virology 2001; 64:157-66
Quinlivan E B, Wang R X, Stewart P W, Kolmoltri C, Regamey N, Erb P, Vernazza Pietro, Swiss HIV Cohort Study
Infections in i/v Drug Users in a Basel Opiate Maintenance Program
Hoffmann M, Bucher H, Bassetti S, Battegay M (2001). Infections in i/v Drug Users in a Basel Opiate Maintenance Program.
May 10, 2001Infections in i/v Drug Users in a Basel Opiate Maintenance Program
May 10, 200169th annual assembly of the Swiss Society of Internal Medicine (SGIM)
Hoffmann Matthias, Bucher H C, Bassetti Stefano, Battegay Manuel
Viral burden in genital secretions determines male-to-female sexual transmission of HIV-1: a probabilistic empiric model
Chakraborty H, Krieger J, Coombs R, Patterson B, Eron J, Fiscus S, Vernazza P, Helms R, Sen P, Cohen M. Viral burden in genital secretions determines male-to-female sexual transmission of HIV-1: a probabilistic empiric model. AIDS (London, England) 2001; 15:621-7.
Mar 30, 2001Viral burden in genital secretions determines male-to-female sexual transmission of HIV-1: a probabilistic empiric model
Mar 30, 2001AIDS (London, England) 2001; 15:621-7
Chakraborty H, Krieger J N, Coombs R W, Patterson B K, Eron J J, Fiscus S A, Vernazza Pietro, Helms R W, Sen P K, Cohen M S
Discontinuation of primary prophylaxis in HIV-infected patients at high risk of Pneumocystis carinii pneumonia: prospective multicentre study
Furrer H, Egger M, Flepp M, Rickenbach M, Boggian K, Schiffer V, Bucher H, Telenti A, Bernasconi E, Rossi M, Opravil M, Swiss HIV Cohort Study. Discontinuation of primary prophylaxis in HIV-infected patients at high risk of Pneumocystis carinii pneumonia: prospective multicentre study. AIDS 2001; 15:501-7.
Mar 9, 2001Discontinuation of primary prophylaxis in HIV-infected patients at high risk of Pneumocystis carinii pneumonia: prospective multicentre study
Mar 9, 2001AIDS 2001; 15:501-7
Furrer H, Egger M, Flepp M, Rickenbach M, Boggian Katia, Schiffer V, Bucher H, Telenti A, Bernasconi E, Rossi M, Opravil M, Swiss HIV Cohort Study
A randomised prospective study to evaluate a rapid HIV-antibody assay in the management of cases of percutaneous exposure amongst health care workers
King A, Osterwalder J, Vernazza P. A randomised prospective study to evaluate a rapid HIV-antibody assay in the management of cases of percutaneous exposure amongst health care workers. Swiss medical weekly : official journal of the Swiss Society of Infectious Diseases, the Swiss Society of Internal Medicine, the Swiss Society of Pneumology 2001; 131:10-3.
Jan 12, 2001A randomised prospective study to evaluate a rapid HIV-antibody assay in the management of cases of percutaneous exposure amongst health care workers
Jan 12, 2001Swiss medical weekly : official journal of the Swiss Society of Infectious Diseases, the Swiss Society of Internal Medicine, the Swiss Society of Pneumology 2001; 131:10-3
King A M, Osterwalder J J, Vernazza Pietro
Combined therapy with saquinavir, ritonavir and stavudine in moderately to severely immunosuppressed HIV-infected protease inhibitor-naive patients
Battegay M, Hirschel B, Bedoucha V, Morgenthaler S, Jaccard C, Malinverni R, Erb P, Sendi P, Flepp M, Bernasconi E, Vernazza P, Swiss HIV Cohort Study. Combined therapy with saquinavir, ritonavir and stavudine in moderately to severely immunosuppressed HIV-infected protease inhibitor-naive patients. HIV medicine 2001; 2:35-42.
Jan 1, 2001Combined therapy with saquinavir, ritonavir and stavudine in moderately to severely immunosuppressed HIV-infected protease inhibitor-naive patients
Jan 1, 2001HIV medicine 2001; 2:35-42
Battegay M, Hirschel B, Bedoucha V, Morgenthaler S, Jaccard C, Malinverni R, Erb P, Sendi P, Flepp M, Bernasconi E, Vernazza Pietro, Swiss HIV Cohort Study
Alternative strategies for anti-HIV treatment
Eron J, Vernazza P. Alternative strategies for anti-HIV treatment. AIDS (London, England) 2001; 15 Suppl 5:S161-9.
Jan 1, 2001Alternative strategies for anti-HIV treatment
Jan 1, 2001AIDS (London, England) 2001; 15 Suppl 5:S161-9
Eron J J, Vernazza Pietro
Malfunction of a unipolar pacemaker system following development of marked subcutaneous emphysema
Schlegel M, Hörler R, Maier M, Rickli H. Malfunction of a unipolar pacemaker system following development of marked subcutaneous emphysema. Schweizerische medizinische Wochenschrift 2000; 130:1845-7.
Dec 2, 2000Malfunction of a unipolar pacemaker system following development of marked subcutaneous emphysema
Dec 2, 2000Schweizerische medizinische Wochenschrift 2000; 130:1845-7
Schlegel Matthias, Hörler R, Maier Margarete, Rickli Hans
Sensitization to human immunodeficiency virus in seronegative exposed partners
Vernazza P, Kahlert C, Fierz W. Sensitization to human immunodeficiency virus in seronegative exposed partners. The Journal of infectious diseases 2000; 182:1810-2.
Dec 1, 2000Sensitization to human immunodeficiency virus in seronegative exposed partners
Dec 1, 2000The Journal of infectious diseases 2000; 182:1810-2
Vernazza Pietro, Kahlert Christian, Fierz W
Clinical progression, survival, and immune recovery during antiretroviral therapy in patients with HIV-1 and hepatitis C virus coinfection: the Swiss HIV Cohort Study
Greub G, Flepp M, Francioli P, Janin P, Hirschel B, Piffaretti J, Boggian K, Erb P, Bürgisser P, Furrer H, Perrin L, Grob P, Battegay M, Ledergerber B, Telenti A. Clinical progression, survival, and immune recovery during antiretroviral therapy in patients with HIV-1 and hepatitis C virus coinfection: the Swiss HIV Cohort Study. Lancet 2000; 356:1800-5.
Nov 25, 2000Clinical progression, survival, and immune recovery during antiretroviral therapy in patients with HIV-1 and hepatitis C virus coinfection: the Swiss HIV Cohort Study
Nov 25, 2000Lancet 2000; 356:1800-5
Greub G, Flepp M, Francioli P, Janin P, Hirschel B, Piffaretti J C, Boggian Katia, Erb P, Bürgisser P, Furrer H, Perrin L, Grob P, Battegay M, Ledergerber B, Telenti A
[Cause of death and autopsy findings in patients of the Swiss HIV Cohort Study (SHCS)]
Semela D, Glatz M, Hunziker D, Schmid U, Vernazza P. [Cause of death and autopsy findings in patients of the Swiss HIV Cohort Study (SHCS)]. Schweizerische medizinische Wochenschrift 2000; 130:1726-33.
Nov 11, 2000[Cause of death and autopsy findings in patients of the Swiss HIV Cohort Study (SHCS)]
Nov 11, 2000Schweizerische medizinische Wochenschrift 2000; 130:1726-33
Semela David, Glatz M, Hunziker D, Schmid U, Vernazza Pietro
Inhibition of small G proteins of the rho family by statins or clostridium difficile toxin B enhances cytokine-mediated induction of NO synthase II
Hausding M, Witteck A, Rodriguez-Pascual F, von Eichel-Streiber C, Förstermann U, Kleinert H. Inhibition of small G proteins of the rho family by statins or clostridium difficile toxin B enhances cytokine-mediated induction of NO synthase II. British journal of pharmacology 2000; 131:553-61.
Oct 1, 2000Inhibition of small G proteins of the rho family by statins or clostridium difficile toxin B enhances cytokine-mediated induction of NO synthase II
Oct 1, 2000British journal of pharmacology 2000; 131:553-61
Hausding M, Witteck Andrea, Rodriguez-Pascual F, von Eichel-Streiber C, Förstermann U, Kleinert H
Long-term hydroxyurea in combination with didanosine and stavudine for the treatment of HIV-1 infection. Swiss HIV Cohort Study
Rutschmann O, Perrin L, Leduc D, Fagard C, Bernasconi E, Malinverni R, Telenti A, Ledergerber B, Opravil M, Bucher H, Vernazza P, Hirschel B. Long-term hydroxyurea in combination with didanosine and stavudine for the treatment of HIV-1 infection. Swiss HIV Cohort Study. AIDS (London, England) 2000; 14:2145-51.
Sep 29, 2000Long-term hydroxyurea in combination with didanosine and stavudine for the treatment of HIV-1 infection. Swiss HIV Cohort Study
Sep 29, 2000AIDS (London, England) 2000; 14:2145-51
Rutschmann O T, Perrin L, Leduc D, Fagard C, Bernasconi E, Malinverni R, Telenti A, Ledergerber B, Opravil M, Bucher H C, Vernazza Pietro, Hirschel B
Cervical squamous intraepithelial lesions in HIV-infected women: prevalence, incidence and regression. European Study Group on Natural History of HIV Infection in Women
Delmas M, Vernazza P, Suligoi B, Sperandeo D, Savonius H, Peña J, Meier F, van den Hoek A, Anzén B, Poveda J, Bergeron C, Hamers F, van Benthem B, Larsen C, Brunet J. Cervical squamous intraepithelial lesions in HIV-infected women: prevalence, incidence and regression. European Study Group on Natural History of HIV Infection in Women. AIDS (London, England) 2000; 14:1775-84.
Aug 18, 2000Cervical squamous intraepithelial lesions in HIV-infected women: prevalence, incidence and regression. European Study Group on Natural History of HIV Infection in Women
Aug 18, 2000AIDS (London, England) 2000; 14:1775-84
Delmas M C, Vernazza Pietro, Suligoi B, Sperandeo D, Savonius H, Peña J M, Meier F, van den Hoek A, Anzén B, Poveda J D, Bergeron C, Hamers F F, van Benthem B, Larsen C, Brunet J B
[HIV superinfection: myth or reality?]
Vernazza P, Bernasconi E, Hirschel B. [HIV superinfection: myth or reality?]. Schweizerische medizinische Wochenschrift 2000; 130:1101-4.
Aug 8, 2000[HIV superinfection: myth or reality?]
Aug 8, 2000Schweizerische medizinische Wochenschrift 2000; 130:1101-4
Vernazza Pietro, Bernasconi E, Hirschel B